Bolaamphiphilic compounds, compositions and uses thereof
AssigneeLauren Sciences LLC
InventorsCharles LINDER, Sarina GRINBERG, Eliahu HELDMAN
Life of this patent
Estimating the term…
Abstract
Bolaamphiphilic compounds are provided according to formula I: HG2-L1-HG1 I where HG1, HG2 and L1 are as defined herein. Provided bolaamphiphilic compounds and the pharmaceutical compositions thereof are useful for delivering HIV active drugs into animal or human brain.
Claims91
A pharmaceutical composition or a formulation comprising a bolaamphiphile complex or nano-sized vesicles;
- wherein the bolaamphiphile complex or nano-sized vesicles comprises one or more bolaamphiphilic compounds and a compound active against HIV, wherein the bolaamphiphilic compound is a compound according to formula 1:
- HG2-L1-HG1 I
- or a pharmaceutically acceptable salt, solvate, hydrate, prodrug, stereoisomer, tautomer, isotopic variant, or N-oxide thereof, or a combination thereof:
- wherein:
- each HG1 and HG2 is independently a hydrophilic head group;
- and
- L1 is alkylene, alkenyl, heteroalkylene, or heteroalkenyl linker;
- unsubstituted or substituted with C1-C20 alkyl, hydroxyl, or oxo;
- and
- a pharmaceutically-acceptable carrier.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.